GT20029
- Phase 2 topical · Androgen-receptor PROTAC · Kintor · trial NCT06692465 · sponsor targets H2 2026 for phase 2b/3 start (China) (said Aug 2026)
Experimental topical drug designed to break down androgen receptors
GT-20029, also known as AR-PROTAC, is an androgen receptor degradation enhancer which is under development for the treatment of androgenetic alopecia and acne. It is used topically in gel form.
Read “GT-20029” on Wikipedia · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 5
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- What’s New in Therapy for Male Androgenetic Alopecia?
- Emerging pharmacotherapies for androgenetic alopecia
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
- Emerging pharmacotherapies for androgenetic alopecia
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- What’s New in Therapy for Male Androgenetic Alopecia?
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
Posts 20
- GT20029 Big Phase 2 Update Results!
- I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.
- GT20029: How It Works for Hair Loss - Hair Loss “Cure”
- GT20029 & KX826 Major Updates from Kintor.
- Anyone immediately lose hope for gt20029 when they realised it’s developed by kintor
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- GT20029 Phase 2 results are out
- Been off Tressless for a few years - what’s the latest on GT20029?
- How different are hair restoration technologies in 2026 as compared to 2016?
- End of Hair loss ( AGA ) ? Since they produce it in china probably we don’t need to wait other 10 yrs😁
- Why is everyone still arguing about PP405 when clascoterone is already heading toward regulatory submission?
- So is GT20029 available on the grey market anywhere?
- Currently Trending Twitter Post: Clascoterone Hailed as New Cure
- GT-20029 should be much more superior than finasteride
- Is breezula the last hope for new drugs?
- Kintor’s GT20029 Phase 1 success
- KX-826 , a small change in the pipeline
- Should I skip Fin since Pyrilutamide + GT20029 are around the corner?
- Does anyone else feel that the hype for PP405 has gone?
- GT20029 Will Replace Finasteride For Hair Loss